Journal of Pain and Symptom Management · 2004 · 516 citations · 46 references
MedicinePharmacokineticsPharmacologyDialysisDrug MetabolismHemodialysisDrug DispositionOpioid AnalgesicsOpioid PharmacologyOpioid TherapyPharmacokinetics In Renal ImpairmentRenal PharmacologyAnalgesic Use In DialysisDialyzability Of DrugsDialyzability Of MedicationsHemodialysis PharmacokineticsMedication Safety In DialysisPharmacokinetics In DialysisRenal Drug SafetyRenal Failure Management
In renal failure, drugs considered safe are also the least dialyzable. The article reviews literature on the metabolism and metabolite activity of commonly used opioids. It examines how renal failure and dialysis alter the pharmacokinetics of opioid drugs and their metabolites. Morphine and codeine should be avoided; hydromorphone or oxycodone require caution and monitoring; methadone, fentanyl, and sufentanil are considered safe.
This article reviews the literature pertaining to the metabolism of several of the commonly used opioids, and the known activity of their metabolites. The effect of renal failure on the pharmacokinetics of these drugs and metabolites is then reviewed. Finally, the effect of renal dialysis on opioid drugs and metabolites is reviewed. Based on the review, it is recommended that morphine and codeine are avoided in renal failure/dialysis patients; hydromorphone or oxycodone are used with caution and close monitoring; and that methadone and fentanyl/sufentanil appear to be safe to use. Note is made that the “safe” drugs in renal failure are also the least dialyzable.
46
Morphine Pharmacokinetics and Metabolism in Humans
Jan Hasselström, Juliette Säwe · Clinical Pharmacokinetics · 1993 · 276 citations